Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial
Publication Type:
Journal Article
Authors:
M S Sulkowski;
Sherman, K.E.;
D. Dieterich;
Bsharat, M.;
Mahnke, L.;
J K Rockstroh;
Gharakhanian, S.;
McCallister, S.;
Henshaw, J.;
Girard, P.M.;
Adiwijaya, B.;
Garg, V.;
Rubin, R.A.;
Adda, N.;
Soriano, V.Source:
Ann Intern Med, Volume 159, Issue 2, p.86-96 (2013)
Keywords:
Antiretroviral,
Antiretrovirals,
Dizziness,
Genotype,
genotype 1,
HCV,
Headache,
hepatitis,
Hepatitis C,
hepatitis C virus,
Hiv,
Hiv-1,
Infection,
Nausea,
Patients,
pharmacokinetic,
pharmacokinetics,
Pruritus,
Ribavirin,
Rna,
Safety,
Sample Size,
sustained virologic response,
Telaprevir,
therapy,
treatment-naive
